NIH-funded research R15 grant

How early microbial exposure affects immune system development

Official title: Biasing immunological development with early life microbial colonization

Funded at University of Massachusetts Boston · NIH-10730933 · Data updated 2026-11-12

This study is looking at how the germs we encounter early in life can shape our immune system and overall health later on, using African Clawed Frogs to help us understand how this works, which might eventually help people with autoimmune diseases.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Boston
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 8, 2023
Project endMay 31, 2026
Funding year2023
Award (this year)$446,702
NIH project number1R15AI174147-01A1
Project IDNIH-10730933 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals under 21 years old who may be at risk for autoimmune conditions.

Less likely to help

Patients with established autoimmune diseases or those over 21 years old may not benefit directly from this research.

What this research studies

This research investigates how the timing and type of microbial exposure during early development can influence the immune system's functioning and health outcomes later in life. Using the African Clawed Frog as a model, the study aims to understand how early life microbial colonization can either promote or suppress immune responses. By examining the effects of specific microbial encounters, researchers hope to uncover critical windows for immune education that could inform future treatments for autoimmune diseases. The findings may provide insights into how similar mechanisms operate in humans.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating autoimmune diseases by understanding how early microbial exposure shapes immune responses.

How similar studies have gone: Other research has shown promising results in understanding immune system development through microbial exposure, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Massachusetts Boston
    Boston, United States
    Active

Researchers

  • Principal investigator: Woodhams, Douglas C — University of Massachusetts Boston
  • Study coordinator: Woodhams, Douglas C

Related research

Other NIH-funded projects on the same topics.

  • Megaplasmids and gut microbes in babies and adults

    Scientists are studying unusually large plasmids found in the gut bacteria of babies and adults to understand how these big DNA pieces might affect health and antibiotic resistance.

    NIH research University of California Berkeley · Berkeley, United States · NIH-11450672

  • Understanding Gut Bacteria in Premature Babies

    This project looks at how antibiotics given to premature babies right after birth affect the helpful bacteria in their gut.

    NIH research University of California Berkeley · Berkeley, United States · NIH-11118883

  • How gut bacteria may steer feeding and behavior in a tiny worm

    This grant explores how gut bacteria influence the feeding choices and behavior of C. elegans, a simple worm often used to study biology.

    NIH research Yale University · New Haven, United States · NIH-11014675

  • Understanding how microbes affect skin health in children with eczema

    This study is looking at how the tiny germs on the skin of kids with eczema might affect their skin condition, with the hope of finding new ways to help manage their symptoms.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11001841

  • How gut bacteria influence the feeding behavior of roundworms

    This study is looking at how the bacteria in the gut can influence the eating habits of tiny roundworms, which helps scientists learn more about how our own gut bacteria might affect our behavior and choices.

    NIH research Yale University · New Haven, United States · NIH-10686470

  • Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide

    This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.

    Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07429864

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.